
Sign up to save your podcasts
Or


This week Sarah continues to fly solo on the podcast with a deep dive into breast cancer with the largest breast cancer charity in the UK, Breast Cancer Now.
Sarah is joined by Sally Kum who is the Associate Director of Nursing, Healthcare, Professional Engagement and Health Information who talks about the incredible work done by the charity around research, funding and support for anyone affected by breast cancer. Sally shares some of the latest findings that show breast cancer diagnoses are increasing in the UK and she explains some of the different types of breast cancer.
This episode was recorded on 29th July which by chance was the same day on which the the National Institute of Clinical Excellence (NICE) announced the NHS would not be making the drug Enhertu available to patients in England.
Enhertu is a life-extending drug for certain women with incurable HER2-low secondary breast cancer, and in an emotional moment, Sarah explores the impact of this and how you can have your voice heard through an online petition.
You can read the Enhertu announcement from NICE here.
We'd like to hear about your experiences with cancer, so please do get in touch if you’d like to share. If you're listening on Spotify, you can use the show’s Q&A feature, or please share your thoughts through our Instagram page at @howlonghaveyougot2024. And please do like and recommend the show as it helps us reach more members of the cancer community.
Studio and recording by A Digital. Production for A Digital by Andrew Armitage.
By Jeremy Langmead and Sarah Edmundson5
33 ratings
This week Sarah continues to fly solo on the podcast with a deep dive into breast cancer with the largest breast cancer charity in the UK, Breast Cancer Now.
Sarah is joined by Sally Kum who is the Associate Director of Nursing, Healthcare, Professional Engagement and Health Information who talks about the incredible work done by the charity around research, funding and support for anyone affected by breast cancer. Sally shares some of the latest findings that show breast cancer diagnoses are increasing in the UK and she explains some of the different types of breast cancer.
This episode was recorded on 29th July which by chance was the same day on which the the National Institute of Clinical Excellence (NICE) announced the NHS would not be making the drug Enhertu available to patients in England.
Enhertu is a life-extending drug for certain women with incurable HER2-low secondary breast cancer, and in an emotional moment, Sarah explores the impact of this and how you can have your voice heard through an online petition.
You can read the Enhertu announcement from NICE here.
We'd like to hear about your experiences with cancer, so please do get in touch if you’d like to share. If you're listening on Spotify, you can use the show’s Q&A feature, or please share your thoughts through our Instagram page at @howlonghaveyougot2024. And please do like and recommend the show as it helps us reach more members of the cancer community.
Studio and recording by A Digital. Production for A Digital by Andrew Armitage.

84 Listeners

1,069 Listeners

1,265 Listeners

128 Listeners

346 Listeners

199 Listeners

92 Listeners

62 Listeners

169 Listeners

58 Listeners

292 Listeners

500 Listeners

53 Listeners

381 Listeners

76 Listeners